Regulatory Story
Go to market news section View chart   Print
GW Pharmaceuticals PLC  -  GWP   

Director/PDMR Shareholding

Released 14:54 30-Nov-2012

RNS Number : 4730S
GW Pharmaceuticals PLC
30 November 2012

GW Pharmaceuticals PLC Director/PDMR Shareholding

GW Pharmaceuticals PLC

30 November 2012

GW Pharmaceuticals PLC

GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company")


Porton Down, UK, 30 November 2012: GW Pharmaceuticals (AIM: GWP) hereby provides notification that the Company was today notified that Dr Geoffrey Guy, a Director and Executive Chairman of the Company, transferred 21,600  0.1 pence ordinary shares of GW Pharmaceuticals plc into his personal pension scheme.

This transaction, representing less than 0.1% of the Company's current issued share capital, was completed when the market price was 62.5 pence per share.

Following this notification Dr Guy's beneficial interest in 17,187,654 GW Pharmaceuticals plc ordinary shares of 0.1 pence each, representing 12.9% of the Company's current issued share capital, remains unchanged.

The total number of shares outstanding in the Company is 133,370,354 ordinary shares of 0.1 pence each.


GW Pharmaceuticals PLC Tel: +44 (0)1980 557 000

Adam George, Company Secretary

Peel Hunt LLP (Nominated Adviser) Tel: +44 (0)207 418 8900

James Steel/Vijay Barathan


This information is provided by RNS
The company news service from the London Stock Exchange

London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.


Director/PDMR Shareholding - RNS